Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.49 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 13/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25466203 | 0.95 | NPC1 (0.50) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL12623225 | 0.93 | NPC1 (0.51) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL1310721 | 0.92 | PTPN1 (0.55) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL29306833 | 0.89 | NPC1 (0.49) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL12623202 | 0.85 | NPC1 (0.48) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL11353246 | 0.84 | POLB (0.49) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL11361497 | 0.84 | POLB (0.49) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL25056606 | 0.83 | NPC1 (0.43) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL27271910 | 0.82 | NFKB1 (0.46) | NPC1POLBPTPN1PTPN2PIN1 | |
| SCHEMBL24489786 | 0.81 | NPC1 (0.39) | NPC1POLBPTPN1PTPN2PIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220181559-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SFC CO., LTD (KR) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220181559-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | VDAC2, TRPA1, TRPM8 | NPC1 4287/4885POLB 1274/4885PTPN1 3514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.